Evidence map›Paper›PMID 27812854›Full record

ArticleJournal of cancer research and clinical oncology2017

Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99

Andrea Papadia, Ignacio Zapardiel, Beatrice Bussi, Fabio Ghezzi, Marcello Ceccaroni, Elena De Ponti, Federica Elisei, Sara Imboden, Begoña Diaz de la Noval, Maria Luisa Gasparri and 6 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.Virchows Archiv : an international journal of pathology · 2021
    Guideline
  7. Trial
  8. Review
  9. Article
  10. Predictors for sentinel lymph node mapping failure using indocyanine green injection in apparent early stages of endometrial cancer: A single-center prospective study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Observational
  18. Review
  19. Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.Geburtshilfe und Frauenheilkunde · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Andrea PapadiaDepartment of Obstetrics and Gynecology, University of Berne, Berne, Switzerland.
Ignacio ZapardielGynaecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Beatrice BussiUnit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Fabio GhezziDepartment of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy.
Marcello CeccaroniDepartment of Obstetrics and Gynecology, Gynecologic Oncology and Minimally-Invasive Pelvic Surgery International School of Surgical Anatomy Sacred Heart Hospital, Negrar, Verona, Italy.
Elena De PontiDepartment of Medical Physics, San Gerardo Hospital, Monza, Italy.
Federica EliseiDepartment of Nuclear Medicine, San Gerardo Hospital, Monza, Italy.
Sara ImbodenDepartment of Obstetrics and Gynecology, University of Berne, Berne, Switzerland.
Begoña Diaz de la NovalGynaecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Maria Luisa GasparriDepartment of Obstetrics and Gynecology, University of Berne, Berne, Switzerland.
Giampaolo Di MartinoUnit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Javier De SantiagoGynaecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Michael MuellerDepartment of Obstetrics and Gynecology, University of Berne, Berne, Switzerland.
Francesca VecchioneUnit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Federica Dell'OrtoUnit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Alessandro BudaUnit of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy. alebuda1972@gmail.com.ORCID http://orcid.org/0000-0002-7093-6862
University of Milano-Bicocca · ITUniversity of Bern · CHAzienda Ospedaliera San Gerardo · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to compare technetium radiocolloid (Tc99

methodsPatients from five European centers with apparently confined clinical stage I endometrial cancer were reviewed. A comparison was made between women who received SLN mapping with pelvic and/or aortic lymphadenectomy (LND), and women who underwent SLN algorithm (SA), was also performed between the two groups.

resultsThree hundred and forty-two (342) women were involved (147 in the Tc99

conclusionsIn this study, fluorescent mapping using ICG resulted equivalent to the standard combined radiocolloid and BD, but real-time SLN mapping achieves a higher bilateral detection rate. The added value that this fast emerging technology promises to give certainly warrants future studies to further consolidate the advantages there are over the standard technique.

Indexed as

AgedEndometrial NeoplasmsFemaleFluorescent DyesHumansIndocyanine GreenLaparoscopyLymphatic MetastasisLymph NodesMiddle AgedNeoplasm StagingOrganotechnetium CompoundsRadiopharmaceuticalsSentinel Lymph NodeSentinel Lymph Node Biopsydithio-bisphosphine tc99mFluorescent DyesIndocyanine GreenOrganotechnetium CompoundsRadiopharmaceuticalsEndometrial cancerFluorescence tracerLaparoscopic surgerySentinel lymph node mapping

Identifiers

PMID27812854
PMCPMC11819327
OpenAlexW2547343898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.